Ipamorelin

Ipamorelin is a pentapeptide growth hormone secretagogue that stimulates the pituitary gland to release endogenous growth hormone¹, making it a selective and natural approach to addressing age-related declines in growth hormone production. The primary therapeutic indication involves supporting patients with diagnosed growth hormone deficiency or insufficiency, where it promotes the body's own hormone production rather than providing synthetic replacement¹. Clinical effects include increased lean muscle mass through enhanced protein synthesis, improved body composition via increased lipolysis, and accelerated recovery from physical strain or exercise¹,². Additional documented benefits encompass improved sleep quality, enhanced metabolic function, and support for cellular regeneration and tissue repair through elevated insulin-like growth factor 1 (IGF-1) levels¹,². With a plasma half-life of approximately two hours, ipamorelin delivers both immediate and sustained growth hormone pulses while promoting these physiological responses without elevating cortisol or other undesired hormonal markers¹.

Ipamorelin, a growth hormone-releasing peptide, is generally well-tolerated with common mild side effects including injection-site reactions like redness, itching, or swelling; headaches; nausea; fatigue; increased appetite; water retention; dry mouth; dizziness; and joint pain or stiffness, most of which are transient and resolve within the first 1-2 weeks as the body adjusts.¹,³,⁴,⁵,⁶,⁷ Less common effects may involve tingling, numbness, flu-like symptoms, or transient increases in prolactin, cortisol, and aldosterone.³,⁴,⁸ Serious or rare side effects requiring immediate medical attention include severe swelling, chest pain, shortness of breath, sudden vision changes, allergic reactions, or significant mood swings.³,⁴ Key safety considerations include avoiding use in those with active cancer, uncontrolled diabetes, pregnancy, breastfeeding, or severe heart disease; monitoring blood sugar due to potential insulin sensitivity impacts; ensuring medical supervision for proper dosing and administration to minimize risks like metabolic disruption or long-term concerns such as insulin resistance, though more human research is needed.¹,³,⁵,⁹ Side effects can often be reduced by verifying reputable sources, proper storage, infection prevention during injection, and consulting a provider for persistent issues.¹,³,⁷

Ipamorelin is a synthetic pentapeptide that acts as a selective agonist of the growth hormone secretagogue receptor (GHSR), primarily GHSR-1a, mimicking the action of ghrelin to stimulate pulsatile growth hormone (GH) release from pituitary somatotroph cells.¹⁰,¹¹,¹²,¹³ This binding activates intracellular pathways including increased cyclic AMP (cAMP) production, protein kinase A (PKA) stimulation, and enhanced hypothalamic GHRH neuron activity, while preserving natural GH pulsatility and negative feedback without elevating cortisol, prolactin, or ACTH levels.¹⁰,¹²,¹³,¹⁴ The resulting GH surge promotes hepatic IGF-1 production, which drives protein synthesis, lipolysis, and tissue regeneration.¹⁰,¹¹,¹² Unlike non-selective GHS peptides, ipamorelin's structural modifications, such as 2-naphthylalanine and D-amino acids, confer high receptor specificity and a short half-life of about two hours.¹⁰,¹¹,¹³